Antitumor effects of monoclonal antibodies to connexin 43 extracellular fragment in induced low-differentiated glioma

Bulletin of Experimental Biology and Medicine

Volumn 153, Issue 1, 2012, Pages 163-169

  Yusubalieva, G M ^a,b   Baklaushev, V P ^a,b   Gurina, O I ^a   Gulyaev, M V ^c   Pirogov, Yu A ^c   Chekhonin, V P ^a,b  

^a N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

^b PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

connexin 43; glioma C6; monoclonal antibodies

Indexed keywords

CONNEXIN 43; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY E2CX43; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER RELAPSE; CANCER TRANSPLANTATION; CONTROLLED STUDY; EXPERIMENTAL ANIMAL; FEMALE; GLIOBLASTOMA; GLIOMA CELL; MOLECULAR DYNAMICS; MORPHOMETRICS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN SYNTHESIS INHIBITION; RAT; SURVIVAL TIME; TUMOR DIFFERENTIATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CONNEXIN 43; FEMALE; GLIOMA; MICE; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 84862755425     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-012-1667-y     Document Type: Article

References (17)

1. VP Baklaushev NF Grinenko EB Tsitrin, et al. 2011 Br. J. Med. Medic. Res. 1 2 35 44
2. VP Baklaushev OI Gurina GM Yusubalieva, et al. 2009 Bull. Exp. Biol. Med. 148 4 725 730 20396778 10.1007/s10517-010-0802-x 1:CAS:528:DC%2BC3cXktFOitLw%3D
3. VP Baklaushev GM Yusubalieva EB Tsitrin, et al. 2011 Drug Deliv. 18 5 331 337 21309693 10.3109/10717544.2010.549527 1:CAS:528:DC%2BC3MXntVynt7Y%3D
4. DC Bates WC Sin Q Aftab CC Naus 2007 Glia 55 15 1554 1564 17823969 10.1002/glia.20569
5. JD Beatty BG Beatty WG Vlahos 1987 J. Immunol. Methods 100 1-2 173 179 2439600 10.1016/0022-1759(87)90187-6 1:STN:280:DyaL2s3lt1aruw%3D%3D
6. J Behrens P Kameritsch S Wallner, et al. 2010 Eur. J. Cell. Biol. 89 11 828 838 20727616 10.1016/j.ejcb.2010.06.003 1:CAS:528:DC%2BC3cXhtFGjs7jL
7. VP Chekhonin VP Baklaushev GM Yusubalieva, et al. 2007 Bull. Exp. Biol. Med. 143 4 501 509 18214311 10.1007/s10517-007-0167-y 1:CAS:528: DC%2BD2sXhtVGmsbfN
8. T Demuth ME Berens 2004 J. Neurooncol. 70 2 217 228 15674479 10.1007/s11060-004-2751-6
9. J Dietrich EL Diamond S Kesari 2010 Expert. Rev. Anticancer Ther. 10 5 171 175 10.1586/era.09.190
10. FB Furnari T Fenton RM Bachoo, et al. 2007 Genes Dev. 21 21 2683 2710 17974913 10.1101/gad.1596707 1:CAS:528:DC%2BD2sXhtlSitLrO
11. F Lefranc M Rynkowski O DeWitte R Kiss 2009 Adv. Tech. Stand. Neurosurg. 34 3 35 19368079 10.1007/978-3-211-78741-0-1 1:STN:280:DC%2BD1M3nvFaqsw%3D%3D
12. JH Lin T Takano ML Cotrina, et al. 2002 J. Neurosci. 22 11 4302 4311 12040035 1:CAS:528:DC%2BD38XksFWgtLg%3D
13. R Oliveira C Christov JS Guillamo, et al. 2005 BMC Cell Biology 6 1 171 175 10.1186/1471-2121-6-7
14. N Prochnow R Dermietzel 2008 Histochem. Cell. Biol. 130 1 71 77 18481075 10.1007/s00418-008-0434-7 1:CAS:528:DC%2BD1cXmtlWit7o%3D
15. L Soroceanu TJ Manning Jr H Sontheimer 2001 Glia 33 2 107 117 11180508 10.1002/1098-1136(200102)33:2<107::AID-GLIA1010>3.0.CO;2-4 1:STN:280:DC%2BD3M3isFSiuw%3D%3D
16. T Suzuki S Izumoto Y Fujimoto, et al. 2005 J. Clin. Invest. 58 2 166 171 1:CAS:528:DC%2BD2MXhvFCqu7s%3D
17. GH Vince M Bendszus T Scweitzer, et al. 2004 Exp. Neurol. 190 2 478 485 15530886 10.1016/j.expneurol.2004.08.015